ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
76.39
-1.52 (-1.95%)
At close: Nov 19, 2025, 4:00 PM EST
76.39
0.00 (0.00%)
After-hours: Nov 19, 2025, 5:59 PM EST
BIB Holdings Information
BIB is an equity ETF with a total of 257 individual holdings.
Total Holdings
25
Top 10 Percentage
154.28%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
76.90M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 39.17% |
| 2 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 34.66% |
| 3 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 20.92% |
| 4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 16.90% |
| 5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 15.64% |
| 6 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 7.86% |
| 7 | AMGN | Amgen Inc. | 5.27% |
| 8 | GILD | Gilead Sciences, Inc. | 4.96% |
| 9 | VRTX | Vertex Pharmaceuticals Incorporated | 4.91% |
| 10 | REGN | Regeneron Pharmaceuticals, Inc. | 3.99% |
| 11 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.20% |
| 12 | AZN | AstraZeneca PLC | 2.47% |
| 13 | INSM | Insmed Incorporated | 2.27% |
| 14 | ARGX | argenx SE | 1.49% |
| 15 | BIIB | Biogen Inc. | 1.32% |
| 16 | UTHR | United Therapeutics Corporation | 1.15% |
| 17 | INCY | Incyte Corporation | 1.08% |
| 18 | ILMN | Illumina, Inc. | 1.00% |
| 19 | RPRX | Royalty Pharma plc | 0.91% |
| 20 | MEDP | Medpace Holdings, Inc. | 0.88% |
| 21 | ROIV | Roivant Sciences Ltd. | 0.75% |
| 22 | NBIX | Neurocrine Biosciences, Inc. | 0.73% |
| 23 | SNY | Sanofi | 0.72% |
| 24 | ASND | Ascendis Pharma A/S | 0.70% |
| 25 | RVMD | Revolution Medicines, Inc. | 0.70% |
As of Nov 18, 2025